請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21432完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 鄭秀玲(Show-Ling Jang) | |
| dc.contributor.author | Chi-Hsien Yang | en |
| dc.contributor.author | 楊祺賢 | zh_TW |
| dc.date.accessioned | 2021-06-08T03:33:55Z | - |
| dc.date.copyright | 2021-02-22 | |
| dc.date.issued | 2021 | |
| dc.date.submitted | 2021-01-26 | |
| dc.identifier.citation | Alcalde Heras, María del Henar. (2014). Building product diversification through contractual R D agreements. R D Management. 44(4). DOI: 10.1111/radm.12075
Bally, Lia, Hood Thabit and Roman Hovorka. (2017) Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist. BMC Medicine 15: 14 DOI: 10.1186/s12916-017-0794-8 Bally, Lia et al. (2016). Accuracy of continuous glucose monitoring during differing exercise conditions. Diabetes Researchand Clinical Practice. Volume 112, 1-5. DOI: https://doi.org/10.1016/j.diabres.2015.11.012 Banbury, Catherine M. and Will Mitchell.(1995). The Effect Of Introducing Important Incremental Innovations On Market Share And Business Survival. Strategic Management Journal 16:161-182 Basu, Sanjay et al. (2018). Estimation of global insulin use for type 2 diabetes. Lancet Diabetes Endocrinol 7(1):25-33 DOI: https://doi.org/10.1016/S2213-8587(18)30303-6 Beran, David, Irl B. Hirsch and John S. Yudkin. (2018). Why Are We Failing to Address the Issue of Access to Insulin. A National and Global Perspective. Diabetes Care Beran, David, Margaret Ewen and Richard Laing. (2016). Insulin in 2016 Challenge and constraints to access. Diabetes Research and Clinical Practice 117:119-121 DOI: 10.1016/j.diabres.2016.06.001 Bekiari, Eleni et al. (March, 2018). Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. Research: open access. Bouncken, Ricarda B., Viktor Fredrich and Paavo Ritala. (2018). Coopetition in New Product Development Alliances: Advantages and Tensions for Incremental and Radical Innovation. British Journal of Management, Vol. 29, 391–410. DOI: 10.1111/1467-8551.12213 Cefalu, William T. et al.(2018). Insulin Access and Affordability Working Group Conclusions and Recommendations. Diabetes Care DOI: https://doi.org/10.2337/dci18-0019 Chandy, Rajesh K. and Gerard J. Tellis. (2000). The Incumbent’s Curse? Incumbency, Size, and Radical Product Innovation. Journal of Marketing. Vol. 64, 1–17. Cohen, Robin A., Michael E. Martinez and Emily P. Zammitti. (2016). Health Insurance Coverage: Early Release of Estimates From the National Health Interview Survey, 2015. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. Daneman, Denis. (2006). Type 1 Diabetes.The Lancet. Volume 367, Issue 9513, 847-858. DOI: https://doi.org/10.1016/S0140-6736(06)68341-4 Dieleman, Joseph L. et al. (2016). US Spending on Personal Health Care and Public Health, 1996-2013. JAMA. 2016;316(24):2627-2646. doi:10.1001/jama.2016.16885 Ernst, H. (1997). The Use of Patent Data for Technological Forecasting: The Diffusion of CNC-Technology in the Machine Tool Industry. Small Business Economics. 9, pages361–381 DOI:10.1023/A:1007921808138 Freeman, Christopher and Carlota Perez. (1988). Structural crises of adjustment, business cycles and investment behavior.Technical change and economic theory.pinter publishers, 1988, p38-66. Gnyawali, Devi R. and Byung-Jin Park. (2011). Co-opetition between giants: Collaboration with competitors for technological innovation. Research Policy. Volume 40, Issue 5, 650-663. DOI: https://doi.org/10.1016/j.respol.2011.01.009 Gregg, Edward W. et al. (2015). Standards of Medical Care in Diabetes—2015. Diabetes Care 2015; 38(Suppl. 1):S1–S2. DOI: 10.2337/dc15-S001 Ingram, Paul and Lori Qingyuan Yue. (2008). Structure, affect and identity as bases of organizational competition and cooperation. The Academy ofManagement Annals 2 (1), 275–303. https://doi.org/10.1080/19416520802211578 Jorde, Thomas M. and David J. Teece. (1990). 'Innovation and Cooperation: Implications for Competition and Antitrust.' Journal of Economic Perspectives, 4 (3): 75-96. DOI: 10.1257/jep.4.3.75 Keith-Hynes, Patrick, Benton Mize, Antoine Robert and Jérôme Place. (2014). The Diabetes Assistant: A Smartphone-Based System for Real-Time Control of Blood Glucose. Electronics 2014, 3, 609-623. DOI: 10.3390/electronics3040609. Kovatchev, Boris P. et al. (2013). Feasibility of Outpatient Fully Integrated Closed-Loop Control. Diabetes Care. DOI: 10.2337/dc12-1965. Kropff, Jort and J. Hans DeVries. (2016). Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects. DIABETES TECHNOLOGY THERAPEUTICS. Volume 18, Supplement 2, 2016. DOI: 10.1089/dia.2015.0345 Lee, Keun and Franco Malerba. (2017). Catch-up cycles and changes in industrial leadership:Windows ofopportunity and responses of firms and countries in the evolution ofsectoral systems. Research Policy 46 (2017) 338–351. http://dx.doi.org/10.1016/j.respol.2016.09.006 Lezama‑Nicolás, René, Marisela Rodríguez‑Salvador, Rosa Río‑Belver and Iñaki Bildosola. (2017). A bibliometric method for assessing technological maturity: the case of additive manufacturing. Scientometrics. 117:1425–1452. DOI: https://doi.org/10.1007/s11192-018-2941-1. Mathews, John A., Mei-Chih Hu and Ching-Yan Wu. (2011). Fast-Follower Industrial Dynamics: The Case of Taiwan’s Emergent Solar Photovoltaic Industry. Industry and Innovation. Vol. 18, No. 2, 177–202. DOI: 10.1080/13662716.2011.541104 Mobasseri, Majid et al.(2020), Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect.10(2): 98–115. DOI: 10.34172/hpp.2020.18 Perez, Carlota and Luc Soete. (1988). Catching up in technology: entry barriers and windows of opportunity. Technical Change and Economic Theory, London: Francis Pinter, pp. 458-479. Patterson, Christopher C. et al. (2019). Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice.DOI: https://doi.org/10.1016/j.diabres.2019.107842 Rodbard, David. (2016). Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities. Diabetes Technology Therapeutics. Schnaars, Steven P. (1994) Managing Imitation Strategies: How Later Entrants Seize Markets from Pioneers (New York: The Free Press). Schoonhoven, Claudia B., Kathleen M. Eisenhardt and Katherine Lyman. (1990). Speeding Products to Market: Waiting Time to First Product Introduction in New Firms . Administrative Science Quarterly 35(1):177. DOI: 10.2307/2393555 Thabit, Hood and Roman Hovorka. (2012). Closed-loop insulin delivery in type 1 diabetes. Endocrinology and Metabolism Clinics 41(1):105–17. doi: 10.1016/j.ecl.2011.12.003. Thabit, Hood and Roman Hovorka. (2016). Coming of age: the artificial pancreas for type 1 diabetes. Diabetologia.;59:1795–805. doi: 10.1007/s00125-016-4022-4. Vigersky, Robert A. (2015). The Benefits, Limitations, and Cost- Effectiveness of Advanced Technologies in the Management of Patients With Diabetes Mellitus. Journal of Diabetes Science and Technology. Vol. 9(2) 320–330. DOI: 10.1177/1932296814565661 Weaver, Kathryn W. and Irl B. Hirsch. (2018). The Hybrid Closed-Loop System: Evolution and Practical Applications. Diabetes Technology Therapeutics. Volume 20, Supplement 2. DOI: 10.1089/dia.2018.0091 Wunker, Stephen. (2012). Better growth decisions: early mover, fast follower or late follower? Strategy Leadership. VOL. 40 NO. 2 2012, pp. 43-48, DOI 10.1108/10878571211209341 Yang, Wenya et al.(2018). Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. DOI: https://doi.org/10.2337/dci18-0007 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21432 | - |
| dc.description.abstract | 本文聚焦於美國數間生產人工胰臟相關醫療器材廠商之間的競合行為。我們探討在此醫材市場中，多角化大廠及專業化之中小廠商間會有何種不同的產品發展方式或者是合作方式。此外我們還利用其專利資料分析後進專業小廠商追趕領先大廠商的腳步是否會在專利技術領域上一致等，來討論後進廠商與領先廠商競爭並進入市場的機會與方式。本文發現人工胰臟廠商之間合作與競爭的軌跡可從幾個角度來分析，包括其專利分類及專利關鍵字或關鍵技術能看出後進廠商聯盟可以與領先廠商的專利技術領域相仿，後進廠商學習的對象與先進廠商也會有許多相同之處。此外領先廠商與後進廠商之間的技術差距關係也持續保持著。但即便如此，後進廠商也針對自己專精的部分不斷精進，並在某些領先廠商所不易兼顧的領域闖出一番成績。吾人認為人工胰臟是對這一代對糖尿病患者非常有益的醫療器材，宜藉由同業廠商間的競爭和合作，來促使其更便宜且好用。 | zh_TW |
| dc.description.abstract | The major focus of this study is on the co-competition behavior among several enterprises related to artificial pancreas (AP) in the United States. We compare the difference of patenting performance, particularly on the patent classes, between large diversified AP firm and a group of small specialized AP firms who are latecomers and cooperate with each other in producing AP. In addition, we analyze latecomers’ learning process through investigating their patent citation behaviors. The track of cooperation and competition in the artificial pancreas market is discovered and can be seen from different points of view in this study. The International Patent Classification (IPC) and technical keywords reveal that the alliance of newcomers could achieve patent similarity to leading enterprises. Besides, new-comers learn from leading enterprises with similar patterns. The gap between leaders and fast-followers remain the same. Nevertheless, newcomers continuously pursue the advancement in R D, and obtain quite successful results in some specific fields which the leading firm may not be able to catch-up. Since the artificial pancreas is one of the most updated medical devices for diabetes patients, how to promote the diffusion rate of AP with cheaper price is very important. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T03:33:55Z (GMT). No. of bitstreams: 1 U0001-2501202103213700.pdf: 5448713 bytes, checksum: 620997aa4bbcb7af3fd7c77ba665a73a (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 口試委員審定書 ……………………………………………………………… i 謝辭 ………………………………………………………………………… ii 中文摘要 …………………………………………………………………… iii 英文摘要 …………………………………………………………………… iv 目錄 ………………………………………………………………………… v 圖目錄 ………………………………………………………………………… vi 表目錄 ………………………………………………………………………… viii 第一章、 緒論 ……………………………………………………………… 1 第一節、研究背景 …………………………………………………… 1 第二節、研究目的 …………………………………………………… 3 第二章、 文獻回顧 ………………………………………………………… 5 第三章、 人工胰臟相關廠商簡介 ………………………………………… 8 第一節、生產連續型血糖偵測器的廠商 ……………………………… 8 第二節、生產胰島素汞的廠商 ………………………………………… 13 第三節、開發演算法的廠商 ………………………………………… 15 第四節、生產人工胰臟的廠商 ………………………………………… 19 第四章、 廠商專利技術比較 ……………………………………………… 22 第一節、廠商之間的競合態樣與問題 ……………………………… 22 第二節、競爭廠商的專利引證與表現比較 ………………………… 24 第三節、廠商技術之間的相似性 …………………………………… 28 第五章、 結論 ……………………………………………………………… 48 參考文獻 …………………………………………………………………… 51 附錄Ａ ………………………………………………………………………… 54 附錄Ｂ ………………………………………………………………………… 56 | |
| dc.language.iso | zh-TW | |
| dc.title | 人工胰臟廠商技術競合的探討 | zh_TW |
| dc.title | A Study on the Co-opetition of Technology among Artificial Pancreas Firms | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 109-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 林惠玲(Hui-Lin Lin),李顯峰(Hsien-Feng Lee) | |
| dc.subject.keyword | 人工胰臟,創新,廠商合作與競爭,多角化大廠,專業化中小企業, | zh_TW |
| dc.subject.keyword | artificial pancreas,innovation,cooperation and competition among firms,large diversified firms,small specialized firms, | en |
| dc.relation.page | 60 | |
| dc.identifier.doi | 10.6342/NTU202100146 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2021-01-26 | |
| dc.contributor.author-college | 社會科學院 | zh_TW |
| dc.contributor.author-dept | 經濟學研究所 | zh_TW |
| 顯示於系所單位： | 經濟學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-2501202103213700.pdf 未授權公開取用 | 5.32 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。